GLP-1 / GLP-1 RA Weight Loss
The shortcut isn't a pill. It's the right pill, prescribed correctly.
GLP-1 / GLP-1 RA Weight Loss
Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are the two FDA-approved GLP-1 medications driving the weight-loss revolution. The right one for you depends on your starting weight, your metabolic markers, your tolerance profile, and your goals — not a one-size-fits-all algorithm.
Your telemedicine consult covers candidacy for both. The physician reviews your situation, contraindications, and goals, then writes for whichever GLP-1 fits. Most patients lose 15–22% of body weight on tirzepatide over a year; semaglutide trends slightly lower but with a smoother side-effect curve for some. We help you pick correctly the first time.
How It Works
Five minutes, from your phone. No appointment, no waiting room.
A licensed provider evaluates your history and goals.
Your protocol ships directly. Ongoing support included.
Free — telemedicine consult with a physician in our network. No lab work required. Medication is billed separately after the physician writes your script.
Start Your Health Questionnaire →6 quick steps. Your card will be saved securely — no charge until a physician reviews and approves your script. If you're not approved, your card is never charged.